#AstraZeneca #lungcancer #NICE #Imfinzi #durvalumab #Tagrisso #osimertinib #NICEpositiverecommendation #NICErecommendation #NHSEngland #NHSWales #ESSCLC #CASPIANPhaseIIItrial #overallsurvivalbenefits #ThoracicOncology #NSCLC #ADAURAphase3trial
pharmatimes.com/news/astraze...
0
0
0
0